Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
Intervalo de ano de publicação
1.
Clin Colorectal Cancer ; 1(2): 117-20, 2001 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-12445370

RESUMO

Approximately 40% of patients treated with curative intent for colorectal carcinoma eventually recur. In about one third of these patients, the lesion is localized and potentially resectable. Typically, the recurrence is characterized by findings on diagnostic imaging studies and may be accompanied by a rise in the serum carcinoembryonic antigen (CEA) levels. In a few patients, however, the asymptomatic rise in CEA is not accompanied by diagnostic findings on computed tomography (CT). We report a case herein, of a patient with rising CEA, noted 1 year after completion of adjuvant chemotherapy for node-positive colorectal cancer. CT and laparoscopic exploration were nondiagnostic. In order to further evaluate the rise in CEA, positron emission tomography (PET) was performed. PET revealed an area of increased uptake in the right lobe of the liver. Resection of the metastatic liver lesion resulted in a subsequent drop in the CEA levels.


Assuntos
Adenocarcinoma Mucinoso/diagnóstico , Neoplasias do Ceco/diagnóstico , Neoplasias Hepáticas/diagnóstico , Tomografia Computadorizada de Emissão/métodos , Adenocarcinoma Mucinoso/patologia , Adenocarcinoma Mucinoso/terapia , Antineoplásicos/uso terapêutico , Antígeno Carcinoembrionário/sangue , Neoplasias do Ceco/patologia , Neoplasias do Ceco/terapia , Colectomia , Terapia Combinada , Feminino , Fluordesoxiglucose F18 , Hepatectomia , Humanos , Neoplasias Hepáticas/secundário , Neoplasias Hepáticas/terapia , Pessoa de Meia-Idade , Metástase Neoplásica , Estadiamento de Neoplasias , Radioimunodetecção/métodos , Compostos Radiofarmacêuticos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA